Tag: InMode

All

HOT STUFF: November 2014

Check out what products are featured in November's Hot Stuff.

National Publications Honor InMode Technologies with Beauty Awards
New from InMode: Morpheus8 Platform and Morpheus8 Body Fractional Technology
InMode Introduces Morpheus8 Body Multi-Pulse Burst Technology
Doctors Investigate Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing
InMode Receives U.S. Patent for Fractional RF Morpheus8
InMode Files ITC Complaint Against ILOODA and its US Distributor, Cutera
InMode Wins Court Judgment Over Counterfeit Morpheus8 Devices

All

Sorry, No Posts Found

All

FDA Clears Restylane Contour for Temple Hollowing

The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.

Dexlevo Showcases PCL Collagen Stimulator Data at IMCAS 2026
FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

Tag: InMode

All

HOT STUFF: November 2014

National Publications Honor InMode Technologies with Beauty Awards

New from InMode: Morpheus8 Platform and Morpheus8 Body Fractional Technology

InMode Introduces Morpheus8 Body Multi-Pulse Burst Technology

Doctors Investigate Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing

InMode Receives U.S. Patent for Fractional RF Morpheus8

InMode Files ITC Complaint Against ILOODA and its US Distributor, Cutera

InMode Wins Court Judgment Over Counterfeit Morpheus8 Devices

All

Sorry, No Posts Found

All

FDA Clears Restylane Contour for Temple Hollowing

Dexlevo Showcases PCL Collagen Stimulator Data at IMCAS 2026

FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis

Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links